Hypertension treatment reduces mortality and cardiovascular events in patients with type 2 diabetes, but it is underused, according to 2 recent studies.
Women with type 1 diabetes may have a higher all-cause mortality risk than men with the condition, as well as higher risk for fatal and nonfatal vascular events, according to a recent study.
Managing diabetes has become more expensive in the past 20 years, mostly due to more spending on drugs, a study found, while a second paper suggested that older patients are more likely to be using medications to control their condition.
This month's quiz asks readers to evaluate a 60-year-old man, diagnosed with type 2 diabetes mellitus during a health insurance evaluation 6 months ago, as a new patient.
Review: In type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA1c without increasing hypoglycemia
Combination treatment with a glucagon-like peptide-1 receptor (GLP-1) agonist and basal insulin was associated with lower HbA1c values, less weight gain, and similar hypoglycemia rates compared to other type 2 diabetes treatment regimens, according to a meta-analysis.
Improved mortality rates in diabetic ICU patients appear to be independent of glucose control, study finds
Improved mortality rates in diabetic ICU patients over the past decade appear to be independent of glucose control, according to a new study.
The FDA approved an app for continuous glucose monitoring, a weight-loss device, a combination diabetes pill, and a new indication for an eye medication in the past month.